Pedro Fragoso Costa
Deutschen Konsortium für Translationale Krebsforschung, Essen University Hospital
Papers
2
Total Citations
12
H-Index
2
About
Pedro Fragosa Costa is a pioneering researcher in the field of nuclear medicine and surgical oncology, with a focus on advancing intraoperative imaging techniques for prostate cancer. His key research areas include Cerenkov Luminescence Imaging (CLI) and radio-guided surgery, particularly in the context of robot-assisted radical prostatectomy (RARP). Costa’s major contribution lies in the first-in-men application of 68Ga-PSMA for intraoperative assessment of tumor margins using CLI, a novel approach that enhances the detection of residual cancer during surgery. His 2019 study, with 4 citations, demonstrated the feasibility of this technique, while his 2021 work, cited 8 times, further characterized radiation protection and occupational exposure during these procedures. These studies represent a significant step toward improving surgical precision and patient outcomes in prostate cancer treatment. Costa’s work bridges the gap between diagnostic imaging and surgical intervention, offering a promising tool for real-time cancer detection. His research has been instrumental in establishing CLI as a viable intraoperative modality, with implications for reducing positive surgical margins and improving recurrence-free survival.
Research Focus
Key Achievements
Top Papers
- 1
- 2